Acute Telogen Effluvium Onset Event Is Associated With The Presence Of Female Androgenetic Alopecia: Potential Therapeutic Implications
October 2013
in “
Dermatologic Therapy
”
Studysummary This study found that severe diets, iron deficiency, and thyroid dysfunction are significant predictors of acute telogen effluvium's association with female androgenetic alopecia.
Our plain-language summary. Not medical advice or a treatment recommendation. Consult a qualified healthcare professional before changing treatment. Full disclaimer
The study found that acute telogen effluvium (ATE) is significantly associated with the presence of female androgenetic alopecia (FAA), with severe diet, iron deficiency, and thyroid dysfunction being the triggering causes with the highest risk of FAA association. Patients suffering from ATE may benefit from different therapeutic approaches depending on the triggering cause to prevent or treat the association with FAA. Minoxidil use appears to improve patient outcomes with a lower percentage of progression to chronic telogen effluvium (CTE), while finasteride-treated patients are associated with the highest percentage of progression to CTE.
